Skip to main content

Soligenix, Inc.

SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000812796

No open-market purchases or sales by Soligenix, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $369.6K in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Soligenix, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of SNGX: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders34340
Shares4.14M4.11M−26.3K (−0.6%)
Value$4.59M$4.35M−$238.0K (−5.2%)

New holders (7)

Institutions that held Soligenix, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to SNGX in Q3 2021
InstitutionSharesValue% of portfolio
IHT Wealth Management, LLC70,150$74.0K0.01%
Two Sigma Securities, LLC58,791$62.0K0.01%
Millennium Management LLC29,570$31.0K0.00%
HRT Financial LP22,659$24.0K0.00%
UBS Group AG8,098$9.00K0.00%
Meridian Wealth Partners, LLC5,000$5.00K0.00%
Farmers & Merchants Investments Inc1$00.00%

Sold out (7)

Institutions that held Soligenix, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of SNGX in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Renaissance Technologies LLC296,111$329.0K
Goldman Sachs Group Inc54,006$60.0K
Perennial Advisors, LLC3,000$3.00K
Citigroup Inc2,000$2.00K
Tower Research Capital LLC (TRC)1,194$1.00K
FMR LLC1$0
Toth Financial Advisory Corp100$0